We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMBC icon
2701
Southern Missouri Bancorp
SMBC
$839M
$3.5K ﹤0.01%
61
+12
+24% +$737
GIC icon
2702
Global Industrial
GIC
$1.52B
$3.5K ﹤0.01%
141
+76
+117% +$2.22K
LBTYA icon
2703
Liberty Global Class A
LBTYA
$3.5B
$3.48K ﹤0.01%
273
+168
+160% +$2.8K
CSAN icon
2704
Cosan
CSAN
$2.77B
$3.48K ﹤0.01%
639
+153
+31% +$1.15K
USHY icon
2705
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
$3.46K ﹤0.01%
+94
New +$3.5K
VWOB icon
2706
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.23B
$3.41K ﹤0.01%
+54
New +$3.49K
IMVT icon
2707
Immunovant
IMVT
$8.17B
$3.39K ﹤0.01%
137
+45
+49% +$1.28K
CLNE icon
2708
Clean Energy Fuels
CLNE
$346M
$3.39K ﹤0.01%
1,349
-203
-13% -$576
SLNO
2709
DELISTED
Soleno Therapeutics
SLNO
$3.37K ﹤0.01%
75
+18
+32% +$933
ASAN icon
2710
Asana
ASAN
$2.12B
$3.37K ﹤0.01%
166
+153
+1,177% +$2.42K
COMP icon
2711
Compass
COMP
$9.62B
$3.35K ﹤0.01%
572
+494
+633% +$3.13K
XPER icon
2712
Xperi
XPER
$338M
$3.34K ﹤0.01%
325
+85
+35% +$794
TRML
2713
DELISTED
Tourmaline Bio
TRML
$3.33K ﹤0.01%
164
+17
+12% +$428
RCKT icon
2714
Rocket Pharmaceuticals
RCKT
$395M
$3.29K ﹤0.01%
262
+190
+264% +$2.86K
BCBP icon
2715
BCB Bancorp
BCBP
$156M
$3.29K ﹤0.01%
278
+60
+28% +$752
FSBW icon
2716
FS Bancorp
FSBW
$318M
$3.29K ﹤0.01%
80
+61
+321% +$2.72K
WRBY icon
2717
Warby Parker
WRBY
$3.25B
$3.27K ﹤0.01%
135
+123
+1,025% +$2.51K
ESQ icon
2718
Esquire Financial Holdings
ESQ
$1.12B
$3.26K ﹤0.01%
41
+1
+3% +$72
FBRT
2719
Franklin BSP Realty Trust
FBRT
$640M
$3.26K ﹤0.01%
260
-96
-27% -$1.24K
MTW icon
2720
Manitowoc
MTW
$675M
$3.25K ﹤0.01%
356
+228
+178% +$2.25K
RLJ icon
2721
RLJ Lodging Trust
RLJ
$1.66B
$3.24K ﹤0.01%
317
+294
+1,278% +$2.85K
UMH
2722
UMH Properties
UMH
$1.32B
$3.21K ﹤0.01%
170
+76
+81% +$1.45K
NIC icon
2723
Nicolet Bankshares
NIC
$3.6B
$3.15K ﹤0.01%
30
+14
+88% +$1.48K
LENZ
2724
LENZ Therapeutics
LENZ
$168M
$3.15K ﹤0.01%
109
+27
+33% +$823
CWCO icon
2725
Consolidated Water Co
CWCO
$484M
$3.13K ﹤0.01%
121
-117
-49% -$2.98K

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.